E-mail this article to yourself or a friend. Enter address:

Trypsin from genetically modified plants (April 15, 2002 – CropChoice news) – ProdiGene, Inc. announced that it will soon be extracting a key pharmaceutical component from genetically modified plants. Trypsin, is a protein used in cell culture and to produce pharmaceuticals, particularly insulin; it usually comes from bovine sources. ProdiGene plans to market this plant-based trypsin by the end of 2002 and achieve full-scale production shortly thereafter. The company received a grant from the National Institutes of Health to genetically modify corn to deliver an edible AIDS vaccine. Source: Cropbiotech Net